Qualigen rises after resuming sales control over its diagnostics platform

Aixcrypto Holdings

05/04/2022 15:06

** Shares of biotech co  QLGN.O  rise ~4% to 66 cents in
early trade 
    ** Co says as of April 1, it has resumed global distribution
and commercial control over its diagnostics platform FastPack
 urn:newsml:reuters.com:*:nGNXtD2t1 
    ** QLGN regained control over FastPack from its marketing
partner Sekisui Diagnostics, with whom co had been collaborating
since 2016 
    ** Co will now receive 100% of the revenue from sales of its
diagnostic platform
    ** Up to Monday's close, QLGN down ~38% YTD

 (Reporting by Bhanvi Satija in Bengaluru)
 ((Bhanvi.Satija@thomsonreuters.com; Outside U.S. +91
9873062788;))